Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Caporali

Showing results (11-20 of 417) with videos related to

Pageof 42
Sort By:
Clinical and Experimental Rheumatology|March 31, 2018
Clinical remission in rheumatoid arthritis and psoriatic arthritisEnnio Lubrano, Federica Mesina, Roberto Caporali
Seminars in Thrombosis and Hemostasis|January 3, 2006
Autoimmunity in thrombotic thrombocytopenic purpuraCamillo Porta, Roberto Caporali, Carlomaurizio Montecucco
Annals of the Rheumatic Diseases|February 16, 2020
What is the real role of ultrasound in the management of juvenile idiopathic arthritis?Rolando Cimaz, Teresa Giani, Roberto Caporali
Clinical and Experimental Rheumatology|September 6, 2018
Clinical implications of peripheral new bone formation in psoriatic arthritis: a literature-based reviewAntonio Marchesoni, Roberto Caporali, Ennio Lubrano
Diabetes, Obesity & Metabolism|June 3, 2026
Could Incretin-Based Weight Loss Unmask a Modifiable Nociplastic Pain Phenotype? A Rheumatological Reading of SURMOUNT-5Jacopo Ciaffi, Roberto Caporali, Francesco Ursini
Paediatric Drugs|April 17, 2020
Dealing with COVID-19 in a Pediatric Rheumatology Unit in ItalyStefania Costi, Roberto Caporali, Rolando Cimaz
Modern Rheumatology|April 6, 2023
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative reviewRoberto Caporali, Fabrizio Conti, Florenzo Iannone
RMD Open|September 24, 2025
If the evidence is there, why are GLP-1 receptor agonists not on-label for hip and knee osteoarthritis in overweight patients?Francesco Ursini, Jacopo Ciaffi, Roberto Caporali
Rheumatology (Oxford, England)|December 18, 2025
Rethinking obesity, immunity, and the promise of anti-obesity therapies in PsAFrancesco Ciccia, Ennio Lubrano, Roberto Caporali
Rheumatology (Oxford, England)|July 1, 2026
Comment on: Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platformJacopo Ciaffi, Roberto Caporali, Francesco Ursini
Pageof 42

Showing results (11-20 of 417) with videos related to

Sort By:
Pageof 42
Clinical and Experimental Rheumatology|March 31, 2018
Clinical remission in rheumatoid arthritis and psoriatic arthritisEnnio Lubrano, Federica Mesina, Roberto Caporali
Seminars in Thrombosis and Hemostasis|January 3, 2006
Autoimmunity in thrombotic thrombocytopenic purpuraCamillo Porta, Roberto Caporali, Carlomaurizio Montecucco
Annals of the Rheumatic Diseases|February 16, 2020
What is the real role of ultrasound in the management of juvenile idiopathic arthritis?Rolando Cimaz, Teresa Giani, Roberto Caporali
Clinical and Experimental Rheumatology|September 6, 2018
Clinical implications of peripheral new bone formation in psoriatic arthritis: a literature-based reviewAntonio Marchesoni, Roberto Caporali, Ennio Lubrano
Diabetes, Obesity & Metabolism|June 3, 2026
Could Incretin-Based Weight Loss Unmask a Modifiable Nociplastic Pain Phenotype? A Rheumatological Reading of SURMOUNT-5Jacopo Ciaffi, Roberto Caporali, Francesco Ursini
Paediatric Drugs|April 17, 2020
Dealing with COVID-19 in a Pediatric Rheumatology Unit in ItalyStefania Costi, Roberto Caporali, Rolando Cimaz
Modern Rheumatology|April 6, 2023
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative reviewRoberto Caporali, Fabrizio Conti, Florenzo Iannone
RMD Open|September 24, 2025
If the evidence is there, why are GLP-1 receptor agonists not on-label for hip and knee osteoarthritis in overweight patients?Francesco Ursini, Jacopo Ciaffi, Roberto Caporali
Rheumatology (Oxford, England)|December 18, 2025
Rethinking obesity, immunity, and the promise of anti-obesity therapies in PsAFrancesco Ciccia, Ennio Lubrano, Roberto Caporali
Rheumatology (Oxford, England)|July 1, 2026
Comment on: Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platformJacopo Ciaffi, Roberto Caporali, Francesco Ursini
Pageof 42